Biotechnology
Is Cassava Sciences Underestimating Their Phase 3 Clinical Trials? (October 2024)
Cassava Sciences is a clinical-stage biotechnology company developing several late-stage treatments for Alzheimer's. A friend recently heard about Cassava in the news and asked me if I had any insights based on the recent biotech data I've been exploring. I thought it was a good opportunity